Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study

Spanish study (n=77,590) reports HIV-positive patients receiving tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) had lower risk for COVID-19 and related hospitalisation vs. those receiving other therapies; and no patient receiving TDF/FTC was admitted to the ICU or died.

Annals of Internal Medicine